Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-benefit of epilepsy surgery.

H Silfvenius1

  • 1Dept. of Neurosurgery, University Hospital, Umeå, Sweden.

Acta Neurologica Belgica
|February 16, 2000
PubMed
Summary
This summary is machine-generated.

Epilepsy surgery (ES) offers significant long-term societal and economic benefits by reducing lost productivity, despite initial costs. Early and successful ES improves employment and quality of life, proving cost-effective compared to medication alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview: epilepsy surgery in developing countries.

Epilepsia·2000
Same author

Cost and cost-effectiveness of epilepsy surgery.

Epilepsia·1999
Same author

World-wide disparities in epilepsy care: a Latin American outlook.

Epilepsia·1999
Same author

Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy.

Epilepsy research·1999
Same author

Carotid angiography in conjunction with amytal testing of epilepsy patients.

Brain and cognition·1997
Same author

Cortical reorganisation of sensory, motor and language functions due to early cortical damage.

Epilepsy research·1996
Same journal

Photon-counting CT-angiography in comparison to digital subtraction angiography and MR-angiography for assessing intra-aneurysmal flow disrupting devices.

Acta neurologica Belgica·2026
Same journal

Multinodular vacuolating neuronal tumor (MVNT) on MRI: distinctive, benign and often overlooked.

Acta neurologica Belgica·2026
Same journal

Diagnostic accuracy of CSF and plasma pTau-181, pTau-217, and pTau-231 for Alzheimer's disease: a diagnostic meta-analysis.

Acta neurologica Belgica·2026
Same journal

Rare Listeria monocytogenes brain abscess presenting as a tunnel-like lesion in an immunocompromised patient.

Acta neurologica Belgica·2026
Same journal

Small-fiber neuropathy and autonomic neuropathy probably related to isolated hyperhomocysteinemia.

Acta neurologica Belgica·2026
Same journal

Repetitive transcranial magnetic stimulation-induced severe hypotension in a patient with Parkinson's disease: a case report.

Acta neurologica Belgica·2026
See all related articles

Area of Science:

  • Neurosurgery
  • Health Economics
  • Epileptology

Background:

  • Epilepsy Surgery (ES) presents a high direct cost, necessitating evaluation of its cost-benefit.
  • Advancements in MRI technology and surgical techniques improve ES accuracy and reduce procedure duration.
  • Societal gains from reduced production loss are a key consideration in ES cost-benefit analyses.

Purpose of the Study:

  • To evaluate the cost-benefit of Epilepsy Surgery (ES) by assessing societal gains from reduced production loss.
  • To analyze the economic impact of ES, considering direct costs against postoperative savings and long-term indirect cost reductions.
  • To determine the health economic justification of re-operation for epilepsy.

Main Methods:

  • Cost-benefit analysis comparing ES with anti-epileptic drug (AED) treatment.

Related Experiment Videos

  • Evaluation of seizure freedom rates (45-90% for resective procedures, 45-50% for re-operation).
  • Assessment of impact on employment, education, cognition, and quality of life.

    • Main Results:

    • Successful ES leads to significant improvements in employment and income, particularly with early intervention in children.
    • ES is more cost-effective than AED treatment alone when measured by seizure-free rates.
    • Re-operation for epilepsy is health-economically justified, yielding seizure freedom in 45-50% of cases.
    • While ES can improve quality of life, cognitive impairment post-surgery limits its overall benefit.

    Conclusions:

    • Epilepsy surgery is a cost-effective intervention with substantial long-term economic and societal benefits, especially when performed early.
    • Successful surgical outcomes, including seizure freedom and improved employment, justify the initial investment in ES.
    • Further research into optimizing ES outcomes and minimizing adverse effects like cognitive impairment is warranted.